US Patent Issued to Guangzhou Cellprotek Pharmaceutical on April 7 for "Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,282, issued on April 7, was assigned to Guangzhou Cellprotek Pharmaceutical Co. Ltd. (Guangdong, China).

"Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury" was invented by Bingzheng Lu (Guangdong, China), Yupin Chen (Guangdong, China), Yana Wang (Guangdong, China), Jiayu Huang (Guangdong, China), Chunhui Huang (Guangdong, China) and Jiesi Chen (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is use of 5Alpha-androst-3Beta,5,6Beta-triol or an analogue, a deuterated compound or a pharmaceutically acceptable salt thereof in the manufact...